AstraZeneca looks to recreate UK vaccine deal globally

May 19, 2020

AstraZeneca have been in negotiation with global governments to make coronovirus vaccine production deals similar to one it agreed with Britain.The drugmaker worked with the University of Oxford on a COVID-19 vaccine hopeful that has already generated a deal to supply millions of doses to the United Kingdom.

The company is in talks with the Coalition for Epidemic Preparedness Innovations (CEPI) and the Global Alliance for Vaccines and Immunisation (Gavi).

Per the deal, AstraZeneca will manufacture up to 30 million doses by September with a promise to deliver 100 million doses in total in the U.K. London pledged 65.5 million pounds in funding for the vaccine.

Read the Reuters report